Search

Displaying results 4711 - 4720 of 10000 in total
  1. Drug

    Mepramidil

    go.drugbank.com/drugs/DB20025
    Experimental

    The usage of the INN stem '-dil' in the name indicates that Mepramidil is a vasodilator. Mepramidil has a monoisotopic molecular weight of 463.24 Da.

  2. Drug

    Mapinastine

    go.drugbank.com/drugs/DB20076
    Experimental

    The usage of the INN stem '-astine' in the name indicates that Mapinastine is a antihistaminic. Mapinastine has a monoisotopic molecular weight of 410.28 Da.

  3. Drug

    Palinavir

    go.drugbank.com/drugs/DB20083
    Experimental

    The usage of the INN stem '-vir' in the name indicates that Palinavir is a antiviral. Palinavir has a monoisotopic molecular weight of 708.4 Da.

  4. Drug

    Zanoterone

    go.drugbank.com/drugs/DB21384
    Experimental

    The usage of the INN stem '-terone' in the name indicates that Zanoterone is a antiandrogen. Zanoterone has a monoisotopic molecular weight of 416.21 Da.

  5. Drug

    Bamirastine

    go.drugbank.com/drugs/DB21186
    Experimental

    The usage of the INN stem '-astine' in the name indicates that Bamirastine is a antihistaminic. Bamirastine has a monoisotopic molecular weight of 527.29 Da.

  6. Drug

    Barmastine

    go.drugbank.com/drugs/DB21253
    Experimental

    The usage of the INN stem '-astine' in the name indicates that Barmastine is a antihistaminic. Barmastine has a monoisotopic molecular weight of 483.24 Da.

  7. Indication

    Venous Hypertension Ulcers

    go.drugbank.com/conditions/DBCOND0079472
    Drugs: Balsam of Peru · Hyaluronic acid
    Synonyms: Skin ulcer NOS, Venous ulcer NOS
  8. Indication

    Venous Leg Ulcers (VLU)

    go.drugbank.com/conditions/DBCOND0147916
    Drugs: Pentoxifylline · Sulodexide
    Synonyms: Venous ulcer NOS, Skin ulcer NOS
  9. Drug

    Atacicept

    go.drugbank.com/drugs/DB06399
    ApprovedInvestigational

    Atacicept is a recombinant fusion glycoprotein that joins the ligand-binding portion of the human TACI receptor to a modified IgG1 Fc domain, allowing it to bind and neutralize two cytokines: B cell activating factor (BAFF) and A Prolife...

  10. Drug

    Romidepsin

    go.drugbank.com/drugs/DB06176
    ApprovedInvestigational

    Romidepsin is a selective inhibitor of histone deacetylase, approved in the US in 2009 for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy.